grajul
- 19 Feb 2004 13:39
Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul
greekman
- 23 Feb 2016 07:28
- 944 of 968
Result of the fund raising.
Deltex has received valid acceptances from Qualifying Shareholders in respect of 10,693,408 Open Offer Shares, including applications for 6,303,861 Open Offer Shares under the Excess Application Facility. This represents approximately 57.0 per cent. of the maximum Open Offer Shares available under the Open Offer.
The low take up says it all regarding the lack of confidence in the companies future.
The last similar fund raiser for another IAM company I am invested in was around 4 times over subscribed and yet the sp is now lower in that company than it was a month ago, the date of the offer, which does not bode well for a company that's offer was under subscribed.
It matters little what individuals think, positive or negative, it's the collective of 43.0 per cent that the market will concentrate on.
I expect the sp to drop by .25 to .50p by close today.
hangon
- 23 Feb 2016 13:32
- 945 of 968
greekman, I fear you may be right, but the sp has risen since the "uncertainty" they'd get anything . . . . so I guess the money raised "should" be spent carefully.... However, they've not used it to make profits in the past, so while I subscribed a little, I'm only "hopeful"
They are supplying decent "Kit" - but it's into the US so difficult o understand exactly how they are meeting expectations . . . from this end it's not good and they really need to develop extra kit . . . and not just the same in pink/chrome etc.
Execs need to spend some time in the US to discover what Kit is missing - and satisfy that need - pref. something reasonably simple with a small customer-base ( This avoids being overloaded with demand, allowing Competition in. ).... pref. it would be something that's unrelated to existing kit, but which is "At home" in a hospital
environment; so their limited Sales-Force can sell "twice-per-trip".
I wonder - did the Issue cover the Debt they wanted to clear?
+ I suspect the Issue wasn't a "good-enough deal" to excite larger Shareholders.... so the Advisors badly misjudged the Market - it's particularly tough at this time.
Yr comments re other Co. placings . . .
Were they in the Hype regions, I wonder?
Folks can pay silly money for stocks without L-T track records
- whereas Deltex has one that's clearly getting worse! Er, IMHO. and I suspect that was why it only got half the amount.
EDIT-(5April2016)- Low take-up is also a factor of the prevailing mind-set . . . with folks thinking China may implode and US in Debt too, it's possible that for Deltex folks are unduly worried....but all-in-all I fear Deltex needs mind-changing at the TOP. . . and this 2016-money will go the same way as previous Dilution.
Sadly I have little regard for this business and the sp rather agrees with that.
The fact is they can't sell this in the UK - so why don't they make something that does sell - thereby their profits "could" be spent on Investors+Reserach . . . although I get the impression there is minimal Research . . . as they believe the path to Riches only needs finding the right clothing . . . whereas I think a decent Map and GPS would be more useful.
EDIT-(11May2016).Release of new WA probe in the UK ( Yet available in US, since Nov"15)....ah well they needed somewhere to place the older product. . . . sp 3.38p
EDIT-(22May2016)-sp up 16%, but still below 5p.
EDIT (03Oct2016) Greekman - re. partnering/probes....Sphere looks promising...?
EDIT (3Nov2016)-sp+10% (~3.5p) on Southern NHS buying £30K-worth . . . Huh!
EDIT (17Nov2016)-Greekman, it's small pots...but does indicate they can break into fresh ground - if NHS continues to by "probes" then / more / elsewhere in UK.
EDIT(7Nov2016)-7% fall today, are the rats leaving already? What I fail to understand is why whoever designed probes+m/c hasn't thought of ANOther product, which would add to Sales and Medic-Interest. Yr point about "partnering" I would change to "Agent" - where they take a 'related' product ( so the same salesforce needs only minor training ), from a Company that isn't active (or too Small) in D's territories. This is beneficial to both parties, esp. [DEMG]. if they can rebrand -OR- if the Probes m/c can be used to power/display Both products. When I was working for Co's- they were open to Customer needs, that's the way to best conduct "research" - no point in developing Kit that no-one wants/Afford.... The probe/NHS link is slightly good.....but look at the "Time" it's taken. Are the Sales-force part-timers? Too many Execs aren't out selling! IMHO.
EDIT (7March2017)-sp 3.6p doesn't look like Mkt believes there's much Prospect... Oh dear!
EDIT ( 26May2017)- sp 4p1 It rose on news they're offering "Veterinary" probes ( Dogs/Cats ), which is another Market-stream . . . . also "owners" may wish to have the best-chance of success, etc. Pity they can't do Horses - that's where real money lies, but maybe they just shoot them? Dunno. It's much better than "no-News"
EDIT (11July2017)- sp 3.6 looks like it's not recovering... & News re Korea?
EDIT(21Sept2017)- Seems they've sold two "xxx" to France. sp 3.16 though Dirs seem to be buying - but not £100k-worth.
greekman
- 23 Feb 2016 14:46
- 946 of 968
Hi Hangon,
Fully agree re other kit, which means I have to comment on my old chestnut re Deltex partnering, but as you know I have mentioned it so many times.
As for the other companies placings, not really in the hype area as they have the backing of some very big players.
I do though agree that over subscribe does not always mean that the future is rosy, thinking about tech companies for example.
greekman
- 04 Nov 2016 11:39
- 947 of 968
As this is the first post of over 7 months it just goes to show how interest has almost completely faded in Deltex.
As to todays RNS, it is again tea tin change money, but anything to do with the NHS taking monitors and probes has to be encouraging.
greekman
- 24 Nov 2016 17:43
- 948 of 968
This shares price has a trend of sinking like the proverbial lead balloon.
Arf Dysg
- 25 Jan 2017 12:25
- 949 of 968
I see the announcement re: Korea, and the fact that Deltex thinks that their Korean sales will go from £0.3m last year to £0.6m this year.
I note that, in the announcement, Deltex says that the Korean decision refers specifically to ODM and not to any other kind of monitoring. Oh, dear, that means that Lidco can't try to claim that it applies to them.
2517GEORGE
- 22 Mar 2017 10:44
- 950 of 968
Directors buying
MaxK
- 30 Dec 2017 21:13
- 952 of 968
It's no surprise €l Greco, this about sums them up.
greekman
- 05 Jan 2018 07:44
- 953 of 968
Trading Update.
The following says it all.
Overall revenues of £5.9m (2016 £6.3m)
International revenues down by 5%
UK revenues reduced by 18%
December sales were down with c.£0.3m of bulk orders not repeated from 2016
Loss for 2017 expected to be higher than market expectations
Cash at 31 December of £0.2m (2016: £0.6m).
The rest means nothing, because they said almost the same, word for word at the same time last year................And it changed nothing..............................
Discussions on the future funding of the Group are in progress and the Company expects to be able to make a further announcement in the near future(again).
However, Deltex enters 2018 positioned to benefit from momentum in the USA and other focus export markets. The UK continues to be a difficult market due to NHS funding constraints (change enters 2018 for 2017 and its same again).
We have substantially reduced our rate of operating cash consumption (again)
The Company is currently in the implementation phase of achieving this goal in a number of territories worldwide, operating directly in the UK, USA, Spain and Canada and through distribution arrangements in a further 30 countries. (again, bla bla bla)
I would not be surprised if the sp by end of year (if the company is still quoted) as being a true 1p share, or lower).
Absolutely pathetic..........Albert Einstein was right, perhaps he knew about Deltex.
hangon
- 06 Jan 2018 14:12
- 954 of 968
Came as a bit of a shock ( 46% fall =yes, - well almost), reading News on M-AM today, [ sp=1p ], =Oh deary, dear. Well I guess this could be the end; as the Market gives up all hope that any future money will go the same way. Quite apart from Greekman... I believe they should be concentrating on the UK market - you get that right and supply elsewhere is a bonus. It's true the NHS is penny-pinching and might not be a big spender.... so why not apply their "Development" to an area where there are willing customers? This may mean making something completely different . . . . but why not? Let the Sales of existing kit continue, with minimal spend.... while concentrating on the Next Big Thing. Clearly, the Sales for their Blood-pressure kit is insuficent to keep the Co. going. . . .
This I has been the fact for many years....only Execs fail to see it....and from the Co-Speak it remains, so.
/
Greekman - I kinda agree, but trying to tackle the NHS is a No-No from the start as they only deal with suppliers "on the list" ( the partnering which you suggested only spreads the profits). Whilst it may be true there are no "Private Healthcare" operative that would sustain this business...fact is even World-wide they are struggling for meaningful sales . . . and until then the daily costs represent enormous losses. They need to get into a product-line that is WANTED.... quite simple, but they are focussed only on selling probes . . . and that's difficult.
greekman
- 08 Jan 2018 07:55
- 955 of 968
Hi Hangon,
re concentrating on the Uk market..............the problem was/is that they did concentrate on the UK market for years and they got almost nowhere, in fact if they had not spread their wings to foreign shores, they would have already gone bust.
Deltex's problem, especially with the UK market is they have always required a hammer to crack the home market, but instead of partnering (which many small medical equipment companies do) they stubbornly refused to consider such a move and were left trying to break into the market with a toffee hammer, where a sledgehammer was needed.
2517GEORGE
- 17 Jan 2018 12:08
- 956 of 968
Held these until a few years ago managed to get out before the demise in the sp. Today some good news from the USA, good luck to long term sufferers like gm.
greekman
- 17 Jan 2018 14:48
- 957 of 968
Hi George,
Sold out almost fully a few years ago but with quite a loss, only hold a token of 12573 shares now. All my posts since then (and many before) have been disparaging of the company and how it's been run, but I can't argue that this new contract is anything but good.
It all now depends on how Deltex follow this up. They should be shouting such contracts from the roof tops, but I fear that the current management will sit on this quietly and after an initial lift in the sp, it will do it's usual slide back down again.
I am not knocking anything in the RNS, but it is again my exasperation at what could be that breaks through every time.
So come on EP use this result as the selling tool it should be.
greekman
- 23 Jan 2018 08:11
- 958 of 968
Please sir, can I have some more.
It looks like the begging bowl is out again.
I hope that the general meeting does not pass the resolution needed to enable the proposals to proceed, reason being that the Deltex boat is sinking too fast to save.
I appreciate my feeling have gone back to negative, very quickly, but i did not expect the begging bowl to be passed round so quickly within a few days of such a positive contract RNS.
It could also be that the offer of 1.25p could be higher than an open market price.
If I felt that this was the last time of begging for more good money after bad and that it would be used in a positive way, I might put a few more quid in, but EP will continue with the same broken down business model that he has been following for many years.
If they don't get the money, the company could be forced to either sell up or partner up, either scenario probably better for us long suffering shareholder than the current drip, drip of pain.
hangon
- 27 Jan 2018 15:02
- 959 of 968
A plague on all your houses... is probably not right - but all Execs should be steering this business. The RNS I'm reading suggest they are raising £350k.... which seems very low to me..... Is this all they need... OR could it be they don't think punters will support any more? As a 1-product Co ( ie STILL !), this is a poor prospect, unless it's a product that folks are falling-over to buy...
Clearly the Market for probes is severely limited... so why not try ( yep, TRY ), something else....? I should have sold-out when Greekman did a couple of years (?), ago.... about 5p-ish rather than just over 1p now. The "Offer" is very close to MktPrice... so I'll be surprised the "Oversubscription" holds, but then I'm often wrong.
greekman
- 09 May 2018 07:56
- 960 of 968
Tried to undue to underlining without success.
This is the first posting since January which shows how the interest in Deltex has died.
Results
Although throughout the year we have seen increased contracts, mainly in the USA the company is still not in profit, although we were told that profit was near a couple of years ago.
Operating loss is still evident but reduced by £0.4m to £2.0m (2016: £2.4m), so loss only reduced by 20%.
Group revenues £0.4m lower at £5.9m (2016: £6.3m) one has to wonder why, if they have more units and probes being used.
Even with gross margins improved to 75% (2016: 68%) the company is still loosing money.
With statements such as 'Revenues from US managed care contracts down 20% at £0.4m (2016: £0.5m) due to one lost account' '2017 was partially offset by a disappointing second half sales performance'. You have to wonder why they are loosing accounts if the system is as good and cost effective as the company states (I do believe it is as good as we have been told, so there's the mystery.
I have never seen a product that has so many positive trials and feedback fail so miserably to almost by results contradict the figures from those trials.
As many of us have stated, It can only be down to the companies business model.
Can anyone can give a better explanation. Also does anyone think that by year end, or even by the first quarter of 2019, the company will finally be in profit.
With the separate release re the TrueVueTM System, (which I read first finishing with a positive feeling that was reversed on reading the results) I still feel the SP will either open down, or if upward will as ever drift ever downward again.
greekman
- 10 May 2018 07:11
- 961 of 968
Hard Choice.
Just seen the Investor day RNS.
Unfortunately on the same day I have been invited to the annual, watching different paints drying day. Will probably go to that event as likely to be more exciting.
hangon
- 15 May 2018 16:46
- 962 of 968
That reads like something to watch.... +hope to attend the Deltex Bash. ...sorry "Event" so I guess I'm hoping the presentation will be more than the same-old.
At ~3p share-price, there is a lot of explaining to do - Perhaps they should stand for Foreign Secretaries . . . always a good laugh.
EDIT....18May2018 - I'll probably stay-away:- what are they going to tell me that isn't already known? The sp says it all( Today= 1p25- Oooer) ....might be a waste of a rail-fare -and- my time!
greekman
- 20 Jun 2018 08:15
- 963 of 968
Just the Andy Mears mention is the only change I can see from the same rubbish put out for the previous several years. Optimising, maximise, addressable, exploring new ways, challenges etc.
I doubt anyone attending the AGM fell for this guff.
Deltex Medical's management, led by Andy Mears, will be working on optimising the Group's sales and marketing activities in order to maximise the Group's revenues and addressable markets. The team will also be exploring new ways of addressing the challenge that many hospitals currently only use haemodynamic monitoring for high risk patients.